Clinical Trials Browser

Adenocarcinoma Of Esophagus

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Carcinoma, Hepatocellular

Esophageal Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Anus Neoplasms

Carcinoma, Hepatocellular

Locally Advanced Rectal Cancer (LARC)

Esophageal Squamous Cell Carcinoma

Radiation Therapy

Radiotherapy

Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma

Carcinoma, Hepatocellular

Pancreatic Neoplasms

Esophageal Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Esophageal Squamous Cell Carcinoma

Carcinoma, Hepatocellular, Liver Neoplasms

Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Colonic Neoplasms

Radiation Injuries, Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

Stomach Neoplasms

Anal Canal Carcinoma, Anus Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

Anus Diseases, Anus Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Neoplasms, Neoplasms, Squamous Cell

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Rectal Neoplasms

Esophageal Malignant Neoplasm, Local Recurrence

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Esophageal Squamous Cell Carcinoma

Esophageal Neoplasms

Rectal Neoplasms

Esophageal Squamous Cell Carcinoma

Stomach Neoplasms

Deglutition Disorders, Esophageal Neoplasms

Anal Canal Carcinoma, Anus Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Clinical Trials

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

LAP100

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

KANALRAD

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

A Study to Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell Carcinoma

SENECA

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

PREDIR-NEOREC

KEYNOTE 975

SBRTvsTACE

CONKO-007

SUMC-EC-002

Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma

Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer

CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients

CRTCOESC

ARTC-HCC

Sintilimab Plus NCT or NCRT Versus NCRT for ESCC

Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer

Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer

PSSR

A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer

Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer

Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy

Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients

RuCorT-01

RuCorT-02

RuCorT-03

RectumSIB

JCOG1801

Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer Recurrence

Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer

Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer

Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma

ROCS

Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer

A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma

Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)

Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.

Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas

Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed

DCOECRT